Latest News by Industry
BAUDETTE, Minn. (AP) — BAUDETTE, Minn. (AP) — ANI Pharmaceuticals Inc. (ANIP) on Thursday reported a loss of $4.2 million in its fourth quarter.
The Baudette, Minnesota-based company said it had a loss of 28 cents per share. Earnings, adjusted for non-recurring costs and stock option expense, were 76 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 68 cents per share.
The drugmaker posted revenue of $94.2 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $86.8 million.
For the year, the company reported that its loss widened to $47.9 million, or $3.05 per share. Revenue was reported as $316.4 million.
ANI expects full-year earnings in the range of $2.09 to $2.59 per share, with revenue in the range of $360 million to $385 million.
ANI shares have increased 7% since the beginning of the year. The stock has increased 17% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a ANIP">Zacks stock report on ANIP at https://www.zacks.com/ap/ANIP